Ipratropium bromide inhalation solution

Rx Albuterol sulfate and ipratropium bromide inhalation solution ... 

Atrovent inhalation solution is administered by oral inhalation with the aid of a nebulizer. It contains ipratropium bromide 0.02% (anhydrous basis) in a sterile, isotonic... 

Anticholinergics Atrovent (Boehringer Ingelheim) Ipratropium bromide Solution for inhalation 0.02% (500 pg/vial). In 25 unit dose vials per foil pouch. Preservative free... 

Benzalkonium chloride at concentrations greater than 0.005 mg/ml causes histamine release from mast cells in vitro. At a concentration of 0.03 mg/ml an excess of 90% of the histamine content is released (5). This is in the range of the minimum concentration of benzalkonium chloride recommended as a disinfectant (0.025 mg/ml). Inhalation of benzalkonium chloride nebulizer solution causes concentration-related falls in FEVi in patients with asthma (6). Benzalkonium chloride 0.3 mg also causes a temporary increase in airway reactivity to histamine. This amount of benzalkonium chloride is similar to that in a 2.5 mg dose from a multidose vial of salbutamol (7). Ipratropium containing benzalkonium chloride 0.25 mg/ml causes bronchoconstriction in a proportion of patients with asthma. BronchodUatation is seen when 2 ml (0.5 mg) of preservative-free ipratropium bromide solution is inhaled (8). Benzalkonium chloride 0.1 mg/ml does not alter the bronchodUator effect of salbutamol. The difference between salbutamol and ipratropium may be the lower concentration of benzalkonium chloride in the salbutamol solution (0.1 versus 0.25 mg/ml) and the greater potency and more rapid onset of the bronchodilator response to salbutamol (9). Individual case reports suggest that... 

---